Tauns Laboratories (TSE:197A) Beginning Cash Position: 円0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:197A Tauns Laboratories Inc TSE:197A
14 GF Score
Price 円503.00
! 9 Warning Signs
View Full Analysis

What is Tauns Laboratories Beginning Cash Position?

Tauns Laboratories TSE:197A 14 Beginning Cash Position is 円0 Mil as of Mar. 2026. GuruFocus rates TSE:197A with a GF Score™ of 14/100. The stock has 9 warning signs investors should review.

Tauns Laboratories's Beginning Cash Position for the quarter that ended in Mar. 2026 was 円0 Mil.

Tauns Laboratories's annual Beginning Cash Position increased from Jun. 2024 (円1,244 Mil) to Jun. 2025 (円9,425 Mil) but then declined from Jun. 2025 (円9,425 Mil) to Jun. 2026 (円9,267 Mil).

Tauns Laboratories Beginning Cash Position Related Terms

Tauns Laboratories Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Tauns Laboratories's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tauns Laboratories Beginning Cash Position Chart

Tauns Laboratories Annual Data
Trend Jun22 Jun23 Jun24 Jun25 Jun26
Beginning Cash Position
1,992.60 6,347.42 1,244.38 9,424.89 9,266.63

Tauns Laboratories Quarterly Data
Jun22 Jun23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:197A
14GF Score
Tauns Laboratories Inc TSE:197A
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tauns Laboratories Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of 円0 Mil mean?
Tauns Laboratories (TSE:197A) has a Beginning Cash Position of 円0 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Tauns Laboratories and its competitors.
Is Tauns Laboratories' Beginning Cash Position too high?
Tauns Laboratories' current Beginning Cash Position is 円0 Mil. Overall, Tauns Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Tauns Laboratories' Beginning Cash Position compare to ISRG and BDX?
Tauns Laboratories' Beginning Cash Position of 円0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Tauns Laboratories and its competitors. Tauns Laboratories's current Beginning Cash Position is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tauns Laboratories stock overvalued right now?
Tauns Laboratories (TSE:197A) has a current Beginning Cash Position of 円0 Mil. The current Beginning Cash Position is 円0 Mil. Tauns Laboratories' overall GF Score™ is 14/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Tauns Laboratories (TSE:197A), the current Beginning Cash Position is 円0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Tauns Laboratories Business Description

Address 761-1 Kamishima Izunokuni-shi, Shizuoka, JPN, 410-2325
Tauns Laboratories Inc is engaged in development, manufacture and sales of in vitro diagnostics and research reagents. Its product include Capilia Flu Neo, Capilia Adeno Neo, Capilia RSV Neo, Capilia hMPV, etc.
14GF Score

Get the complete analysis for TSE:197A

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円503.00
Price